Pure Global

Brief Pain Exposure Therapy for Fibromyalgia (BPET) Study - Trial NCT06208514

Access comprehensive clinical trial information for NCT06208514 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Fibromyalgia. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06208514
Recruiting
behavioral
Trial Details
ClinicalTrials.gov โ€ข NCT06208514
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Brief Pain Exposure Therapy for Fibromyalgia (BPET) Study
Brief Pain Exposure Therapy for Fibromyalgia - A Pilot Study

Study Focus

Fibromyalgia

Brief pain exposure therapy (BPET)

Interventional

behavioral

Sponsor & Location

University of Michigan

Ann Arbor, United States of America

Timeline & Enrollment

N/A

Mar 04, 2024

Jul 01, 2025

30 participants

Primary Outcome

Change in pain intensity based on the Numeric Pain Rating Scale between day 1 (T1) and day 60 (T5)

Summary

This study is intended to test whether a brief Zoom-based behavioral treatment can help
 adults with fibromyalgia learn effective strategies for reducing pain, disability and other
 problems that can come with fibromyalgia (such as depression or anxiety).

ICD-10 Classifications

Fibromyalgia
Myalgia
Fibrothorax
Cervicalgia
Epidemic myalgia

Data Source

ClinicalTrials.gov

NCT06208514

Non-Device Trial